欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7905/001
药品名称Lamotrigin Syri Pharma 20mg/ml Suspension zum Einnehmen
活性成分
    • Lamotrigine 20.0 mg/ml
剂型Oral suspension
上市许可持有人Syri Pharma Limited 1 Windmill Lane D02 F206 Dublin 2, Ireland
参考成员国 - 产品名称Germany (DE)
Lamotrigin Syri Pharma 20 mg/ml Suspension zum Einnehmen
互认成员国 - 产品名称
    • Austria (AT)
    • Slovak Republic (SK)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Denmark (DK)
      Lamotrigin ”Desitin”
    • Poland (PL)
      Lamotrigin Desitin 20 mg/ml Zawiesina doustna
    • Belgium (BE)
      Lamotrigin Desitin 20 mg/ml suspensie voor oraal gebruik
    • Estonia (EE)
    • Netherlands (NL)
    • Czech Republic (CZ)
      Lamotrigin Desitin 20 mg/ml Perorálnísuspenze
    • Luxembourg (LU)
    • Romania (RO)
      Lamotrigin Desitin 20 mg/ml Suspensie orală
许可日期2025/11/06
最近更新日期2025/12/10
药物ATC编码
    • N03AX09 lamotrigine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase